NEJM Evidence
@NEJMEvidence
NEJM Evidence, a new journal from NEJM Group, presents innovative #OriginalResearch and fresh, bold ideas in #ClinicalTrial design and clinical decision-making.
06-08-2021 14:04:23
2,4K Tweets
30,2K Followers
1,7K Following
“Data-driven approaches have the potential to improve efficiency in the identification of the most important drivers of [heterogeneity of treatment effect] from RCTs.” Full article by Rishi J Desai et al.: eviden.cc/4cupGhU
Muthu Vaduganathan
![“Data-driven approaches have the potential to improve efficiency in the identification of the most important drivers of [heterogeneity of treatment effect] from RCTs.” Full article by @Rishidesai11 et al.: eviden.cc/4cupGhU @mvaduganathan](https://pbs.twimg.com/media/GK49gsSaoAAWJPC.jpg "NEJM Evidence (@NEJMEvidence) on Twitter photo 2024-04-11 14:15:04 “Data-driven approaches have the potential to improve efficiency in the identification of the most important drivers of [heterogeneity of treatment effect] from RCTs.” Full article by @Rishidesai11 et al.: eviden.cc/4cupGhU @mvaduganathan")